LFTSF (LifeTech Scientific) Total Current Assets: $330.1 Mil (As of Dec. 2025)


LFTSF LifeTech Scientific Corp LFTSF
96 GF Score
Price $0.23
GF Value $0.36
! 4 Warning Signs
View Full Analysis

What is LifeTech Scientific Total Current Assets?

LifeTech Scientific LFTSF 96 Total Current Assets is $330.1 Mil as of Dec. 2025. GuruFocus rates LFTSF with a GF Score™ of 96/100 and a GF Value™ of $0.36. The stock has 4 warning signs investors should review.

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. LifeTech Scientific's total current assets for the quarter that ended in Dec. 2025 was $330.1 Mil.

LifeTech Scientific  (OTCPK:LFTSF) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

LifeTech Scientific's Liquidation Value for the quarter that ended in Dec. 2025 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=163.292-218.27+0.75 * 22.972+0.5 * 63.168
=-6.2

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LifeTech Scientific Total Current Assets Related Terms

LifeTech Scientific Total Current Assets Historical Data

* Premium members only.

The historical data trend for LifeTech Scientific's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LifeTech Scientific Total Current Assets Chart

LifeTech Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 288.43 200.33 312.48 320.60 330.13

LifeTech Scientific Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 312.48 305.82 320.60 358.38 330.13
LFTSF
96GF Score
LifeTech Scientific Corp LFTSF
Total Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LifeTech Scientific Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

LifeTech Scientific's Total Current Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Current Assets=Cash, Cash Equivalents, Marketable Securities+Total Receivables+Total Inventories+Other Current Assets
=163.292+79.512+63.168+24.153
=330.1

LifeTech Scientific's Total Current Assets for the quarter that ended in Dec. 2025 is calculated as

Total Current Assets=Cash, Cash Equivalents, Marketable Securities+Total Receivables+Total Inventories+Other Current Assets
=163.292+79.512+63.168+24.153
=330.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Frequently Asked Questions Learn more about Total Current Assets →
What does a Total Current Assets of $330.1 Mil mean?
LifeTech Scientific (LFTSF) has a Total Current Assets of $330.1 Mil as of Dec. 2025. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for LifeTech Scientific and its competitors.
Is LifeTech Scientific's Total Current Assets too high?
LifeTech Scientific's current Total Current Assets is $330.1 Mil. Overall, LifeTech Scientific has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does LifeTech Scientific's Total Current Assets compare to ABT and SYK?
LifeTech Scientific's Total Current Assets of $330.1 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Assets for a Medical Devices & Instruments company?
A good Total Current Assets depends on the Medical Devices & Instruments industry context. However, Total Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Assets mean?
A high Total Current Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for LifeTech Scientific and its competitors. LifeTech Scientific's current Total Current Assets is $330.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeTech Scientific stock overvalued right now?
LifeTech Scientific (LFTSF) has a current Total Current Assets of $330.1 Mil. The stock's GF Value™ is $0.36, compared to a current price of $0.23 — trading 35.1% below its estimated fair value. The current Total Current Assets is $330.1 Mil. LifeTech Scientific's overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Assets calculated?
Total Current Assets is calculated from a company's financial statements. For LifeTech Scientific (LFTSF), the current Total Current Assets is $330.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LifeTech Scientific (LFTSF) Overvalued in 2026?

Based on GuruFocus' analysis, LifeTech Scientific stock appears to be undervalued. The current stock price of $0.23 is trading 35.1% below its estimated GF Value™ of $0.36.

Key valuation signals for LFTSF:

  • Total Current Assets: $330.1 Mil
  • GF Value™: $0.36 vs. price of $0.23 (35.1% below fair value)
  • GF Score™: 96/100 with 4 warning signs

No single metric tells the full story. See the LFTSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

LifeTech Scientific Business Description

Other Exchanges 01302:Hong Kong
Address No. 22, Keji 12th Road South, 14th Floor, LifeTech Scientific Building, High-tech Industrial Park, Nanshan District, Shenzhen, CHN, 518063
LifeTech Scientific Corp develops and manufactures also responsible for marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: the Structural heart diseases business, the Peripheral vascular diseases business, and the Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral Vascular Diseases business segment. Geographically, it derives a majority of its revenue from Mainland China, and it also has its presence in Europe, Asia, excluding mainland China and India, India, South America, Africa, and Others.
96GF Score

Get the complete analysis for LFTSF

Total Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.23
Price
$0.36
GF Value